Home › Overweight › California › Santa Ana

Pag-aaral pangklinika para sa Overweight sa Santa Ana, CA

Isang pag-aaral para sa Overweight ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Santa Ana. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Nagre-recruitPhase 3

Southern California Clinical Research, Santa Ana

Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07684235

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Nagre-recruitPhase 2

Southern California Dermatology /ID# 282011, Santa Ana

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07752979

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Nagre-recruitPhase 3

Southern California Clinical Research, Santa Ana

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07392190

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Nagre-recruitPhase 3

Wolverine Clinical Trials, Santa Ana

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07353931

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Nagre-recruitPhase 3

Southern California Clinical Research, Santa Ana

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07321886

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Nagre-recruitPhase 2

Wolverine Clinical Trials, Santa Ana

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 14, 2026 · NCT06897475

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Nagre-recruitPhase 3

Southern California Clinical Research, Santa Ana

Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT07575399

Pag-aaral para sa Overweight sa ibang lungsod

Iba pang pag-aaral sa Santa Ana

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.